The present invention provides compounds of Formula (I): Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
本发明提供了式 (I) 的化合物:式(I)或其立体异构体、同系物或药学上可接受的盐或溶液,其中所有变量如本文所定义。这些化合物是选择性 LPA 受体
抑制剂。